Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,962,237
-$1,825,619 QoQ
Shares Held
47,192
-15.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#536
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $318,890,544 across 18 Drug Manufacturers - General names. GILD ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
362,958 | $92,180,442 | |
| 2 | LLY |
ELI LILLY & Co
|
68,037 | $81,605,624 | |
| 3 | ABBV |
AbbVie Inc.
|
222,751 | $56,053,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
208,546 | $26,798,161 | |
| 5 | AMGN |
Amgen Inc
|
53,858 | $19,503,058 | |
| 6 | NVS |
Novartis AG
|
92,390 | $14,479,360 | |
| 7 | PFE |
Pfizer Inc
|
360,280 | $8,675,542 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
129,525 | $7,463,230 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,962,237 | 47,192 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $7,787,856 | 55,879 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,097,599 | 49,679 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $5,337,546 | 48,086 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $5,122,304 | 46,201 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,705,315 | 41,993 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,320,978 | 35,953 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,415,430 | 28,810 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,987,425 | 28,967 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,431,533 | 33,195 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,129,739 | 38,634 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,982,985 | 39,805 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,631,168 | 34,140 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,744,776 | 21,029 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,600,759 | 18,646 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,170,259 | 18,970 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $932,218 | 15,082 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $836,520 | 14,071 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $1,033,675 | 14,236 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,047,400 | 14,995 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $128,217 | 1,862 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $161,575 | 2,500 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $160,098 | 2,748 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $154,941 | 2,452 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $184,732 | 2,401 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $160,734 | 2,150 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||